Prospective Randomized Evaluation of an Ultra Conservative Approach to Implantable Defibrillator (ICD) Programming in Patients With a Left Ventricular Assist Device (LVAD).
| Status: | Active, not recruiting |
|---|---|
| Conditions: | Cardiology |
| Therapuetic Areas: | Cardiology / Vascular Diseases |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 3/25/2017 |
| Start Date: | October 2013 |
| End Date: | June 2017 |
We propose to study a strategy empirically applied for the past 6 months at a high volume
LVAD center (Vanderbilt Heart and Vascular Institute). This utilizes an ultra conservative
device programming strategy to maximize battery longevity, avoid inappropriate implantable
cardioverter defibrillator (ICD) therapy, improve quality of life through reduction in
overall shock burden, and potentially avoid unnecessary device generator changes prior to
transplant. Avoiding CIED (cardiac implantable electronic device) change out device
procedures prior to transplant is desirable.
LVAD center (Vanderbilt Heart and Vascular Institute). This utilizes an ultra conservative
device programming strategy to maximize battery longevity, avoid inappropriate implantable
cardioverter defibrillator (ICD) therapy, improve quality of life through reduction in
overall shock burden, and potentially avoid unnecessary device generator changes prior to
transplant. Avoiding CIED (cardiac implantable electronic device) change out device
procedures prior to transplant is desirable.
Inclusion:
- Age ≥ 18
- Advanced Heart Failure
- Scheduled for Heartmate II LVAD implant
- With existing ICD
Exclusion:
-Age < 18
We found this trial at
1
site
2201 West End Ave
Nashville, Tennessee 37232
Nashville, Tennessee 37232
(615) 322-7311
Phone: 615-875-5500
Vanderbilt University Vanderbilt offers undergraduate programs in the liberal arts and sciences, engineering, music, education...
Click here to add this to my saved trials
